Literature DB >> 15888766

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of cancers of unknown primary site (CUP).

E Briasoulis1, C Tolis, J Bergh, N Pavlidis.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15888766     DOI： 10.1093/annonc/mdi804

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  12 in total

1.  MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin.

Authors:  Manuela Ferracin; Massimo Pedriali; Angelo Veronese; Barbara Zagatti; Roberta Gafà; Eros Magri; Maria Lunardi; Gardenia Munerato; Giulia Querzoli; Iva Maestri; Linda Ulazzi; Italo Nenci; Carlo M Croce; Giovanni Lanza; Patrizia Querzoli; Massimo Negrini
Journal:  J Pathol       Date:  2011-06-01       Impact factor: 7.996

2.  Volume-based predictive biomarkers of sequential FDG-PET/CT for sunitinib in cancer of unknown primary: identification of the best benefited patients.

Authors:  Yifei Ma; Wei Xu; Ruojing Bai; Yiming Li; Hongyu Yu; Chunshan Yang; Huazheng Shi; Jian Zhang; Jidong Li; Chenguang Wang; Jianru Xiao
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-09-07       Impact factor: 9.236

3.  A case of long-term recurrence-free poorly differentiated neuroendocrine carcinoma of lymph nodes treated by surgical resection without any chemotherapy.

Authors:  Shigeo Hisamori; Hiroshi Okabe; Akihiko Yoshizawa; Yoshiharu Sakai
Journal:  Int J Clin Oncol       Date:  2010-03-12       Impact factor: 3.402

4.  The Role of 18 FDG PET-CT in Evaluation of Unknown Primary Tumours.

Authors:  N K Saidha; M Ganguly; Harkirat Singh Sidhu; Samir Gupta
Journal:  Indian J Surg Oncol       Date:  2013-03-09

5.  Gemcitabine and irinotecan as first-line therapy for carcinoma of unknown primary: results of a multicenter phase II trial.

Authors:  Shernan G Holtan; Preston D Steen; Nathan R Foster; Charles Erlichman; Fabiola Medeiros; Matthew M Ames; Stephanie L Safgren; David L Graham; Robert J Behrens; Matthew P Goetz
Journal:  PLoS One       Date:  2012-07-17       Impact factor: 3.240

6.  Cancers of unknown primary origin (CUP) are characterized by chromosomal instability (CIN) compared to metastasis of know origin.

Authors:  Jonas Vikeså; Anne Kirstine H Møller; Bogumil Kaczkowski; Rehannah Borup; Ole Winther; Ricardo Henao; Anders Krogh; Katharina Perell; Flemming Jensen; Gedske Daugaard; Finn C Nielsen
Journal:  BMC Cancer       Date:  2015-03-19       Impact factor: 4.430

7.  Cancer of unknown primary: Registered procedures compared with national integrated cancer pathway for illuminating external validity.

Authors:  Anne-Kirstine Dyrvig; Knud Bonnet Yderstræde; Oke Gerke; Peter Bjødstrup Jensen; Søren Hess; Poul Flemming Høilund-Carlsen; Anders Green
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

8.  Performance-weighted-voting model: An ensemble machine learning method for cancer type classification using whole-exome sequencing mutation.

Authors:  Yawei Li; Yuan Luo
Journal:  Quant Biol       Date:  2020-12-07

9.  Gene expression profiling may improve diagnosis in patients with carcinoma of unknown primary.

Authors:  J Bridgewater; R van Laar; A Floore; L Van'T Veer
Journal:  Br J Cancer       Date:  2008-04-15       Impact factor: 7.640

10.  Cervical lymph node carcinoma metastasis from unknown primary site: a retrospective analysis of 154 patients.

Authors:  Yan Wang; Sha-Sha He; Yong Bao; Xiu-Yu Cai; Hai-Yang Chen; Xing-Li Yang; Dan-Ming Chen; Li-Xia Lu; Yong Chen
Journal:  Cancer Med       Date:  2018-04-02       Impact factor: 4.452
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.